Cardiac arrest is a life-threatening circumstance. While the etiologies 5H5T outlined in Advanced Cardiac Life Support (ACLS) protocols are widely recognized, the definite pathophysiology may be obscured at the first time. Promptly identifying the key factors can prevent irreversible damage. This case report presents a 72-year-old male patient who was hospitalized due to two episodes of cardiac arrest, accompanied with respiratory acidosis. Subsequently, the patient was admitted to the intensive care unit repeatedly for the same situation. During the investigation for hypercapnia, the patient was found to have reduced respiratory drive, leading to central sleep apnea. The results of cerebrospinal fluid (CSF) analysis and brain magnetic resonance imaging (MRI) both suggested autoimmune en-cephalitis. Testing for paraneoplastic neurological syndromes (PNS) revealed the presence of anti-Hu antibodies in both CSF and serum. Subsequent chest computed tomography (CT) revealed mediastinal lymphadenopathy, and a biopsy performed via video-assisted thoracic surgery (VATS) confirmed the final diagnosis of small cell lung cancer. The patient was treated with a combination of chemotherapy, surgery, corticosteroids, and plasma exchange to prevent the progression of the paraneoplastic neu-rological syndrome. Paraneoplastic neurological syndromes are rare disorders. Anti-Hu antibody is highly associated with malignancy, contributing to brainstem injury and impaired sensitivity to partial pressure of carbon dioxide. Consequently, carbon dioxide accumulation results in severe respiratory acidosis, which may ultimately precipitate cardiac arrest. Moreover, neurological symptoms often pre-cede the diagnosis of cancer. Therefore, thorough evaluation and timely intervention for paraneoplastic neurological syndromes are crucial to mitigating disease severity and preventing irreversible damage.